Large-cap Health Care company Hims & Hers Health has logged a 5.6% change today on a trading volume of 22,325,637. The average volume for the stock is 31,173,726.
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. Based in San Francisco, United States the company has 1,637 full time employees and a market cap of $13,094,896,640.
The company is now trading 22.19% away from its average analyst target price of $47.42 per share. The 12 analysts following the stock have set target prices ranging from $25.0 to $85.0, and on average give Hims & Hers Health a rating of hold.
Over the last 52 weeks, HIMS stock has risen 208.8%, which amounts to a 193.7% difference compared to the S&P 500. The stock's 52 week high is $72.98 whereas its 52 week low is $16.05 per share. Based on Hims & Hers Health's average net margin growth of 1.6% over the last 6 years, its core business is on track for profitability and its strong stock performance may continue in the long term.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 1,476,514 | 126,038 | 9 | 400.0 |
| 2023 | 872,000 | -23,546 | -3 | 75.0 |
| 2022 | 526,916 | -65,678 | -12 | 70.0 |
| 2021 | 271,878 | -107,659 | -40 | -233.33 |
| 2020 | 148,757 | -18,114 | -12 | 86.21 |
| 2019 | 82,558 | -72,064 | -87 |
